Relevant Species Selection for Preclinical Safety Studies of Medicines: A Review
INTRODUCTION. The use of relevant species of laboratory animals in preclinical safety studies during the development of novel medicines provides valuable information for assessing the risks and benefits of such medicines for humans. The appropriate species are selected upon consideration of scientif...
Saved in:
| Main Authors: | G. N. Engalycheva, R. D. Syubaev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2025-04-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/460 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Results of Preclinical Studies Assessing the Effect of Riamilovir on the Reproductive Function and Postnatal Growth of Offspring in Laboratory Animals
by: A. U. Sabitov, et al.
Published: (2023-10-01) -
WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review
by: G. N. Engalycheva, et al.
Published: (2024-12-01) -
PretoxTM: a text mining system for extracting treatment-related findings from preclinical toxicology reports
by: Javier Corvi, et al.
Published: (2025-02-01) -
Comparison of hematological blood parameters when studying chronic toxicity of Protigen feed additive
by: Lilia I. Sabirzyanova
Published: (2024-12-01) -
Interpretation of toxicological research data in establishing the no observed adverse effect level (NOAEL) for medicinal products
by: K. L. Kryshen, et al.
Published: (2025-07-01)